Market Overview:
Benztropine mesylate API is a drug used to treat Parkinson's disease and extrapyramidal symptoms. It is also used as an adjunct in the treatment of akathisia, dyskinesia, and dystonia. The global benztropine mesylate API market was valued at US$ XX Mn in 2017 and is projected to grow at a CAGR of XX% over the forecast period (2018-2030), reaching a value of US$XX Mn by 2030. The global benztropine mesylate API market has been segmented on the basis of purity into ≥98%.
Product Definition:
Benztropine Mesylate is an anticholinergic agent used to treat parkinsonism and extrapyramidal disorders. It is also used as an adjunct in the treatment of drug-induced psychosis.
Purity≥98%:
Purity 98% is a crystalline powder, which is white in color. It has a purity level of more than 99%. Purity 98% has no taste and odor. It's produced using an automated high-purity process with less than 0.1% impurities, such as water, ethanol, carbon dioxide or other gases and particles that are heavier than air. The product is used for producing benztropine mesylate API (AMPA).
Purity
Purity level of 98% is considered as the highest purity level and it's used in benztropine mesylate API market. Purity levels lower than 98% are called impure products. Lower purity levels result in loss of quality attributes such as color, odor, taste, and overall product value.
Application Insights:
Benztropine mesylate injection was the largest application segment in 2017 and accounted for a market share of over 92% in 2018. The product is used as an antiparkinson agent, which improves muscle movement and reduces rigidity & tremor.
Regional Analysis:
North America dominated the global benztropine mesylate API market in 2017. The presence of a large number of manufacturers coupled with stringent regulatory guidelines is expected to drive the demand for low-cost benztropine mesylate APIs over the forecast period. In addition, increasing cases of Parkinson’s disease are also expected to fuel market growth during the forecast period.
Asia Pacific is anticipated to witness significant growth over the next eight years owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatment options. Furthermore, an increase in disposable income levels and medical tourism will also contribute towards regional market development during this period.
Growth Factors:
- Increasing prevalence of Parkinson's disease and other neurological disorders
- Growing demand for generic drugs
- Rising awareness about the benefits of benztropine mesylate API therapy
- Technological advancements in the pharmaceutical industry
- Expansion of distribution channels
Scope Of The Report
Report Attributes
Report Details
Report Title
Benztropine Mesylate API Market Research Report
By Type
Purity≥98%, Purity<98%
By Application
Benztropine Mesylate Injection, Benztropine Mesylate Tablets, Others
By Companies
Dr. Reddy's Laboratories, Aspen API, Fine Chemicals Corporation PTY Ltd, ARCH PHARMALABS LIMITED, Apothecon Pharmaceuticals, Hunan Huateng Pharmaceutical Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Benztropine Mesylate API Market Report Segments:
The global Benztropine Mesylate API market is segmented on the basis of:
Types
Purity≥98%, Purity<98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Benztropine Mesylate Injection, Benztropine Mesylate Tablets, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Dr. Reddy's Laboratories
- Aspen API
- Fine Chemicals Corporation PTY Ltd
- ARCH PHARMALABS LIMITED
- Apothecon Pharmaceuticals
- Hunan Huateng Pharmaceutical Co., Ltd.
Highlights of The Benztropine Mesylate API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity≥98%
- Purity<98%
- By Application:
- Benztropine Mesylate Injection
- Benztropine Mesylate Tablets
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Benztropine Mesylate API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Benztropine mesylate API is a drug used to treat schizophrenia and other psychiatric disorders. It is also used to prevent or reduce the symptoms of Parkinson's disease.
Some of the major players in the benztropine mesylate api market are Dr. Reddy's Laboratories, Aspen API, Fine Chemicals Corporation PTY Ltd, ARCH PHARMALABS LIMITED, Apothecon Pharmaceuticals, Hunan Huateng Pharmaceutical Co., Ltd..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Benztropine Mesylate API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Benztropine Mesylate API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Benztropine Mesylate API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Benztropine Mesylate API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Benztropine Mesylate API Market Size & Forecast, 2020-2028
4.5.1 Benztropine Mesylate API Market Size and Y-o-Y Growth
4.5.2 Benztropine Mesylate API Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity≥98%
5.2.2 Purity<98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Benztropine Mesylate Injection
6.2.2 Benztropine Mesylate Tablets
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Benztropine Mesylate API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Benztropine Mesylate API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity≥98%
9.6.2 Purity<98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Benztropine Mesylate Injection
9.10.2 Benztropine Mesylate Tablets
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity≥98%
10.6.2 Purity<98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Benztropine Mesylate Injection
10.10.2 Benztropine Mesylate Tablets
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity≥98%
11.6.2 Purity<98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Benztropine Mesylate Injection
11.10.2 Benztropine Mesylate Tablets
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity≥98%
12.6.2 Purity<98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Benztropine Mesylate Injection
12.10.2 Benztropine Mesylate Tablets
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity≥98%
13.6.2 Purity<98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Benztropine Mesylate Injection
13.10.2 Benztropine Mesylate Tablets
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Benztropine Mesylate API Market: Competitive Dashboard
14.2 Global Benztropine Mesylate API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Dr. Reddy's Laboratories
14.3.2 Aspen API
14.3.3 Fine Chemicals Corporation PTY Ltd
14.3.4 ARCH PHARMALABS LIMITED
14.3.5 Apothecon Pharmaceuticals
14.3.6 Hunan Huateng Pharmaceutical Co., Ltd.
